DAIICHI SANKYO, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2010-01-01
- Employees
- 10K
- Market Cap
- $79B
- Website
- http://daiichisankyo.us
Welchol as Monotherapy for Type 2 Diabetes Mellitus
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2014-02-27
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 357
- Registration Number
- NCT00789737
Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2017-06-26
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 562
- Registration Number
- NCT00789750
Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children
- First Posted Date
- 2008-10-29
- Last Posted Date
- 2008-10-29
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 96
- Registration Number
- NCT00781521
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
- First Posted Date
- 2008-10-29
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 21105
- Registration Number
- NCT00781391
Vascular Improvement With Olmesartan Medoxomil Study
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2008-10-15
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 100
- Registration Number
- NCT00772499
- Locations
- 🇺🇸
Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States
A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-18
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 65
- Registration Number
- NCT00754507
A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-18
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 67
- Registration Number
- NCT00755352
Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
- First Posted Date
- 2008-09-17
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 129
- Registration Number
- NCT00754039
A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-17
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 72
- Registration Number
- NCT00753779
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
- First Posted Date
- 2008-07-17
- Last Posted Date
- 2021-04-21
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 270
- Registration Number
- NCT00717769
- Locations
- 🇺🇸
Paddington Testing Co, Inc., Philadelphia, Pennsylvania, United States
🇺🇸Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Miami Research Associates, Miami, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath